Johnson & Johnson now says a second shot of its COVID-19 vaccine is 94% effective against preventing COVID-19, making it comparable to Moderna's and Pfizer's vaccines.
J&J also says adding a booster dose raised immunity.
The company says three of its studies show the vaccine provides long-lasting protection that could be boosted with an extra shot.
The J&J shot has faced challenges during the pandemic, including a period of time when it was pulled from the market over clotting concerns.
So with a second dose possible on the horizon, will those who rolled up their sleeves once for the J&J shot do so again?
"I'll probably get the second dose because I've already got the first one."
Sebastian Thurmond got the J&J vaccine in July.
"I went with the J&J because it was old technology and I don't like needles at all, so I figured one shot was good enough," explained Thurmond. "And it was like a 64% chance of not getting it [COVID]."
Now that percentage is even higher, according to the company's ongoing trial.
It shows giving two doses 56 days apart provided 100% protection against severe COVID-19 and 94% protection against moderate to severe COVID-19 in the United States.
Thurmond hopes this new development encourages others to get vaccinated.
"Quit being hardheaded and just get it done. You'll feel bad after a day or so but just get it done. It's nothing but upsides, basically,” Thurmond added.
He says he also hopes it gains emergency authorization to receive a shot.
------------------------------------------------------------
Stay in touch with us anytime, anywhere.
To reach the newsroom or report a typo/correction, click HERE.
Sign up for newsletters emailed to your inbox. Select from these options: Breaking News, Evening News Headlines, Latest COVID-19 Headlines, Morning News Headlines, Special Offers